References

• 2003The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care1,536 cited
• 2013Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force319 cited
• 2010Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers287 cited
• 1958PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE255 cited
• 2012Financial burden of household out-of pocket health expenditure in Viet Nam: Findings from the National Living Standard Survey 2002–2010244 cited
• 2008Pharmaceutical Policy In China186 cited
• 2013The impacts of health insurance on health care utilization among the older people in China165 cited
• 2010Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications153 cited
• 2010Generic and therapeutic substitutions in the UK: are they a good thing?149 cited
• 2010Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey147 cited
• 2010Funding the Unfundable132 cited
• 2014Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications129 cited
• 2014